FDA: Auvi-Q epinephrine injection recalled

Posted in Latest News on October 30, 2015.

Under a voluntary recall, Sanofi US has recalled all Auvi-Q products on the market in both 0.15 mg and 0.3 mg because of suspected device malfunctions, the FDA announced this week. The product is available to hospitals, retailers and customers.

According to the FDA announcement, the product can deliver the wrong dosage. A patient experiencing allergic reaction could die if the proper dosage is not used.



More Latest News

A New Licensure Experience for Health Care Practitioners
May 15, 2024

E-licensing demonstrates the commitment of the Department to expedite
licensure and verification processes. Learn more by clicking here! Continue reading


2024 Bills Impacting Health Care Professions
May 1, 2024

Click here to view a full list of bill summaries from the 2024 Florida Legislative Session that may impact your profession. Continue reading